title: Medicine. Transatlantic lessons in regulation of mitochondrial replacement therapy.
authors: Harvard Law School, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard University, Cambridge, MA, USA. igcohen@law.harvard.edu.
authors: I Glenn
authors: IG
authors: Cohen
authors: Oxford Uehiro Centre for Practical Ethics, University of Oxford, Oxford, UK.
authors: Julian
authors: J
authors: Savulescu
authors: Warren Alpert Medical School, Brown University, Providence, RI, USA.
authors: Eli Y
authors: EY
authors: Adashi
mesh_terms: D002986:Clinical Trials as Topic; D004272:DNA, Mitochondrial / Q000235:genetics*; D015316:Genetic Therapy / Q000941:ethics / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D006801:Humans; D028361:Mitochondrial Diseases / Q000235:genetics* / Q000517:prevention & control* / Q000628:therapy; D011640:Public Policy; D006113:United Kingdom; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
chemical_list: D004272:DNA, Mitochondrial